Certified by Founder Lodge
VerImmune
United States - Washington DC
START UP
1 Disclosed Funding Rounds $3,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
VerImmune is advancing Anti-tumor Immune Redirection (AIR):
A Breakthrough Therapy that Redirects Pre-Existing Immune Memory
from Childhood Vaccination or Infection to Fight Cancer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 21 ,2023 | Unknown | $3,000,000 |
Mana Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)
